4//SEC Filing
Shea Thomas 4
Accession 0001209191-13-026174
CIK 0001333170other
Filed
May 13, 8:00 PM ET
Accepted
May 14, 4:27 PM ET
Size
9.0 KB
Accession
0001209191-13-026174
Insider Transaction Report
Form 4
Shea Thomas
SVP Manufacturing Operations
Transactions
- Exercise/Conversion
Common Stock
2013-05-13$2.11/sh+5,724$12,078→ 35,795 total - Sale
Common Stock
2013-05-13$12.67/sh−15,724$199,151→ 20,071 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-05-13−5,724→ 4,276 totalExercise: $2.11From: 2009-04-05Exp: 2016-03-04→ Common Stock (5,724 underlying)
Footnotes (2)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2012.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.57 to $12.71. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
Documents
Issuer
NxStage Medical, Inc.
CIK 0001333170
Entity typeother
Related Parties
1- filerCIK 0001429894
Filing Metadata
- Form type
- 4
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 4:27 PM ET
- Size
- 9.0 KB